1. Home
  2. BKU vs NVAX Comparison

BKU vs NVAX Comparison

Compare BKU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BKU
  • NVAX
  • Stock Information
  • Founded
  • BKU 2009
  • NVAX 1987
  • Country
  • BKU United States
  • NVAX United States
  • Employees
  • BKU N/A
  • NVAX N/A
  • Industry
  • BKU Savings Institutions
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BKU Finance
  • NVAX Health Care
  • Exchange
  • BKU Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • BKU 2.6B
  • NVAX 1.3B
  • IPO Year
  • BKU 2011
  • NVAX 1995
  • Fundamental
  • Price
  • BKU $35.89
  • NVAX $6.38
  • Analyst Decision
  • BKU Hold
  • NVAX Buy
  • Analyst Count
  • BKU 11
  • NVAX 5
  • Target Price
  • BKU $40.36
  • NVAX $16.60
  • AVG Volume (30 Days)
  • BKU 791.9K
  • NVAX 5.5M
  • Earning Date
  • BKU 07-23-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • BKU 3.45%
  • NVAX N/A
  • EPS Growth
  • BKU 38.76
  • NVAX N/A
  • EPS
  • BKU 3.21
  • NVAX 2.97
  • Revenue
  • BKU $972,198,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • BKU $13.53
  • NVAX $56.85
  • Revenue Next Year
  • BKU $6.80
  • NVAX N/A
  • P/E Ratio
  • BKU $11.18
  • NVAX $2.12
  • Revenue Growth
  • BKU 11.13
  • NVAX 25.92
  • 52 Week Low
  • BKU $28.21
  • NVAX $5.01
  • 52 Week High
  • BKU $44.45
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • BKU 59.06
  • NVAX 44.45
  • Support Level
  • BKU $34.50
  • NVAX $6.26
  • Resistance Level
  • BKU $35.42
  • NVAX $6.66
  • Average True Range (ATR)
  • BKU 0.75
  • NVAX 0.33
  • MACD
  • BKU 0.08
  • NVAX -0.08
  • Stochastic Oscillator
  • BKU 89.71
  • NVAX 22.16

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: